5100-98-1, name is 3-Chloro-2-iodotoluene, belongs to iodides-buliding-blocks compound, is considered to be a conventional heterocyclic compound, which is widely used in drug synthesis. The chemical synthesis route is as follows. SDS of cas: 5100-98-1
A 0.0757 M solution of P(/-Bu)3 in toluene (5.19 ml_, 0.393 mmol), a solution of 3-chloro-2- iodotoluene a112 (5.0 g, 19.8 mmol) in degassed toluene (10 ml.) and a solution of tert- butylacetate (2.53 g, 21.8 mmol) in degassed toluene (10 ml.) are sequentially added to a mixture of LiHMDS (7.60 g, 45.5 mmol) and Pd(dba)2 (0.226 g, 0.393 mmol) in degassed toluene (35 mL) under stirring in argon. The reaction mixture is stirred at room temperature for 2 h and decomposed by the addition of a saturated NH4CI solution (50 mL). After 15 min, the organic layer is separated, and the aqueous layer is subjected to extraction with diethylether. The combined organic extracts are dried over anhydrous Na2SC>4 and evaporated. The residue (6.38 g) is purified by chromatography on silicagel (petroleum ether/ AcOEt 10/1 v/v). The solvents are removed to afford tert-butyl (2-chloro-6- methylphenyl)acetate a113 as a light-yellow oil (4.80 g). Yield: 100 percent. GC-MS (M+- – (C4H8)): 184.
The synthetic route of 5100-98-1 has been constantly updated, and we look forward to future research findings.
Reference:
Patent; UCB PHARMA S.A.; WO2008/132139; (2008); A2;,
Iodide – Wikipedia,
Iodide – an overview | ScienceDirect Topics – ScienceDirect.com